SEC Form 4 Reporting Owner · CIK 0002121402
Peter F Lebowitz
Director at BridgeBio Oncology Therapeutics Inc
Bought (12 mo)
—
Sold (12 mo)
—
Form 4 Filings
2
Companies
1
Filing Activity
2026-06-18
first filed 2026-03-26
Trading record
Open-market buys
—
0 filings
Open-market sales
—
0 filings
Sales under a 10b5-1 plan
—
No open-market sales
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| BBOTBridgeBio Insider trading | Director | 2 | — | — | — | — |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.